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Abstract 
  
Background: One of our best opportunities for progress against AIDS lies in preventing mothers from passing 
on the HIV virus to their children. Worldwide, close to 2,000 babies are infected with HIV every day, during 
pregnancy, birth or through breast feeding. Most of those infected will die before their fifth birthday. The ones 
who are not infected will grow up as orphans when their parents die of AIDS. New advances in medical 
treatment give us the ability to save many of these young lives. Hence, pregnancy provides a unique opportunity 
for implementing prevention strategies against HIV infection, through early intervention and possibly prevent 
the transfer from mother to child..  Hence this research, Does  screening of pregnant women prevent mother to 
child transmission of HIV? 
Methods: From January 2007 to June 2008, A total of 2956  pregnant women that registered for antenatal 
clinics in a missionary hospital in nsukka were counselled and tested for HIV virus. Rapid test method were 
used, three different kits was employed for the test. CD4+ count was done for the  positive clients and 
subsequent recommend for appropriate ART treatment or prophylaxis. 
Results: A total of 2956 pregnant women  were recruited in the study. Twenty six (0.8%) pregnant women 
tested positive, out of these number eighteen (69.2%) of the positive candidates has CD4+ count ≤ 230 cells/μl . 
this were later placed on ARV prophylaxis till birth after proper adherence counselling. 
Conclusions:  The result show that statistics was significant, also the screening has provide an avenue to 
prevent the child from contacting the virus during labour or breastfeeding, the figure may look very small , but 
in HIV prevention a single life is very much important because through one person the virus can wipe a  whole 
generation. the researcher therefore suggested that screening should be encourage  for all pregnant women after 
due counselling. 
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Introduction 
Two decades have now rolled by, since the first case of AIDS was diagnosed in Nigeria in 
1986. In that period, many individuals, families, communities, businesses and Nigeria at large 
has felt the devastation of the epidemic. There is no community or aspect of the nation that 
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has not yet been affected. Nigeria's burden of care/epidemic now ranks third in the world. 
About 3.8 million people are estimated to be living with the virus in the country [1]. The 
epidemic has not shown signs of slowing down and the prevalence remains unacceptably 
high at 5.0%, as reflected by the 2005 adult sero-prevalence survey[2].  
The global HIV/AIDS pandemics is a major public health problem. At present, there is no 
cure and most activities are aimed at reducing HIV transmission, voluntary counselling and 
testing (HCT) is one of the strategies employed in the effort to control the global HIV/AIDS 
pandemic [3]. Volountary counselling and testing has been found to be effective in changing 
high risk behaviours and more than 40% reduction in unprotected intercourse among 
individuals who received VCT, compared to those who received health information only has 
been reported [4]. Unfortunately, the majority of Nigerians do not know their status and this 
proportion is highest in countries worst affected by the epidemic [5]. HIV/AIDS prevention 
and control strategies in addition to the encouragement of behavioural modification and 
provision of antiretroviral drugs are essential ingredients in the fight against HIV/AIDS. 
Strategies that are most appropriate are the early detection of the various, reduction in casual 
sex, proper blood  screening and prevention of mother to child transmission are much desire 
in pregnant women. 
Pregnant women with HIV  are at risk of transmitting HIV  to their infants during pregnancy, 
birth, or breast feeding and without interventions between 20% and 45% of infants may 
become infected. well over 90% of children under 15 years living with HIV are believed to 
have been infected through mother to child transmission [6].   Despite numerous statements 
of political commitment, a well- defined set of interventions and the know-how required to 
implement them, the vast majority of pregnant women in need of  PMTCT services do not 
receive them, the latest data from the end of 2005 estimating that only 11% of infected 
pregnant women in africa received antiretroviral prophylaxis for PMTCT [7]. Intrapartum 
single dose neverapine to mother, and then to infant within 72 hours of birth, is the 
cornerstone of the PMTCT  approach in  much of Africa: it is 40% efficacious in preventing 
HIV transmission, easy to use , safe and cheap.   Generally  majority (90%) of HIV-positive 
children acquired the virus from their mother; 90% of infected children live in sub-Saharan 
Africa [
 7]. The rate of HIV-1 transmission from mother to child range from 25-40% in less 
developed countries, and from 15-40% in less developed countries, and from 15-25% in more 
developed countries [8]. Child could contact during pregnancy, delivery or breast-feeding.  Momoh.M et al  / International Journal of Pharmaceutical Sciences and Research (IJPSR) 
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Hence this research is to assess the important of screening pregnant women attending 
antenatal clinics to prevent mother to child transmission (PMTCT). 
Materials and Methods 
In this cross-sectional study from January 2007 to June 2008, A total of 2956 pregnant 
women attending antenatal clinics in a missionary hospital Nsukka for  medical services were 
counselled for HIV and testing. About 95 percent of all pregnant women referred to antenatal 
clinics, accepted to participate in this study. All the clients that agreed for the testing were 
properly counselled, and the technicalities in HIV follow up if any were eventually positive 
were clearly stated during counselled period, all the clients satisfied with the pre-testing 
counselling they were therefore refer to HCT centre in the same hospital where testing were 
conducted. Finger prick method were used for blood collection, this was done to all the 
pregnant women for HIV testing. Testing was performed using three different kits. The Stat 
pak and determine were used routinely. Double check gold was used for confirmation and 
also serve as a tire breaker.  CD4+ count were done for the seropositive clients for possible 
placement on antiretroviral drug if any of them fall within the acceptable range for ART after 
complete drug adherence counselling and accept to start the medication. 
 
Results  
A total of 2, 956 pregnant women  attending antenatal clinics  between January 2007 – June 
2008 were enlisted and tested for HIV antibodies. Eighteen (18) cases found tested positive to 
all the two test kits used. CD4+ test was done for all the seropositive pregnant women and 
their range of CD4+ were obtained for possible placement on prophylaxis antiretroviral 
therapy. 
Discussion 
Transmission of HIV infection from mother to child is a major concern for developed as well 
as developing countries [9]. In Nigeria with an estimated if 4.5% population with HIV, This 
call for all adults and the people with risk factor for screening pregnant women inclusive. 
From the study it is estimated  that about 0.6% of the total pregnant women screened at the 
centre, only 18 were positive, out of this number 13 were eligible for ART prophylaxis 
according WHO standard.  The importance of this early detection is to enable prompt 
attention and to put in place measure to safe guide the infant not to contact the virus during 
delivery or during breastfeeding. The WHO standard was that any pregnant women that are 
eligible should be placed on prophylaxis as well given a single dose of niverapine during Momoh.M et al  / International Journal of Pharmaceutical Sciences and Research (IJPSR) 
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labour. The new born baby is also to be given niverapine within the first 72 hours follow by 
zidovuldine depending on the method feeding the mother adopt. Statistics has shown that 
most of the infant that are positive to HIV acquired the virus during birth [10].  Mother-to-
child transmission is the leading cause of HIV infection in children. It remains a major public 
health problem worldwide, with the greatest burden in resource-poor settings. Infants and 
children with HIV are more likely to become ill and die shortly after birth [10]. PMTCT 
programs provide a package of services that ideally include: counseling and testing for 
pregnant women; short-course preventive ARV regimens to prevent mother-to-child 
transmission; counseling and support for safe infant feeding practices; family planning 
counseling or referral; and referral for long-term ART for the child. In addition, where 
possible, these programs serve as an entry point for full ART services for the entire family, 
thus protecting the family unit and preventing the tragedy of a generation of orphans [11].  
One of our best opportunities for progress against AIDS lies in preventing mothers 
from passing on the HIV virus to their children. Worldwide, close to 2,000 babies are 
infected with HIV every day, during pregnancy, birth or through breast feeding. Most of 
those infected will die before their fifth birthday [12]. The ones who are not infected will 
grow up as orphans when their parents die of AIDS. New advances in medical treatment give 
us the ability to save many of these young lives. And we must, and we will, through this early 
detection such as in HCT.  
Statistic has shown that in March 31, 2005, the Emergency Plan had provided support 
for counseling and testing of over 2 million pregnant women. As of the same date, 
Emergency Plan PMTCT efforts had provided support for short-course preventive ARVs for 
198,400 HIV-positive pregnant women in the focus countries. The timely use of such ARVs 
decreases the likelihood of mother-to-child transmission [13]. While it is not possible to 
measure directly the number of paediatric infections averted with Emergency Plan support, it 
is possible to make estimates based on the number of women who have received a preventive 
ARV intervention [14]. An international consensus has developed on an algorithm to 
calculate the number of infections averted. In order to arrive at an estimate, a background 
transmission rate of 35% for all HIV-positive delivering mothers and a reduced transmission 
rate of 16% for mothers receiving short-course preventive ARVs were assumed, based on 
research on mother-to-child transmission in the developing world. The difference, 19%, was 
then applied to the number of women receiving preventive ARVs in the focus countries, 
yielding an estimate of 37,600 infections averted with Emergency Plan support for the fifteen 
african countries between 2002-2005 out of these number, Nigeria account for 776 [15]. Momoh.M et al  / International Journal of Pharmaceutical Sciences and Research (IJPSR) 
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The research here strongly suggested that all pregnant mothers should be advice to go 
for HIV screening, because this will help out reducing the transmission rate especially to the 
innocent infants. On the other hand, according to the American guidelines for screening of 
HIV and AIDS, pregnancy is an indication for HIV testing [16].    Studies have shown that in 
Iran Southeast, prevalence of HIV infection in total population is 0.02%, the study showed 
that HIV seroprevalence rate was 0.05% in pregnant women. In this situation, The author 
said, it is difficult to say, there is no indication for HIV testing on each pregnant women, he 
then suggested that HIV testing should be done if there is a history of a risk factor.  Our study 
here in Nigeria especially in the research is carried it is very imperative to strongly 
recommended that every pregnant women should be advice to go for screening. Through this 
method transmission through mother to child could be seriously reduced and the spread, 
poverty and vulnerability of children will be reduced. 
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